268 related articles for article (PubMed ID: 9876628)
21. Inclusion complex effect on the bioavailability of clotrimazole from poloxamer-based solid suppository.
Balakrishnan P; Song CK; Cho HJ; Yang SG; Kim DD; Yong CS; Choi HG
Arch Pharm Res; 2012 Jul; 35(7):1169-75. PubMed ID: 22864739
[TBL] [Abstract][Full Text] [Related]
22. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 5. Theophylline.
Ammar HO; Ghorab M; El-nahhas SA; Omar SM; Ghorab MM
Pharmazie; 1996 Jan; 51(1):42-6. PubMed ID: 8999434
[TBL] [Abstract][Full Text] [Related]
23. [Physical and chemical characterization of allantoin-beta-cyclodextrin inclusion complex].
Gafiţanu C; Popescu C; Singurel G; Macocinschi D
Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):173-6. PubMed ID: 15688779
[TBL] [Abstract][Full Text] [Related]
24. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
Rawat S; Jain SK
Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
[TBL] [Abstract][Full Text] [Related]
25. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
26. Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-dichloro(dipyridine)platinum(II) by complexation with beta-cyclodextrin.
Horvath G; Premkumar T; Boztas A; Lee E; Jon S; Geckeler KE
Mol Pharm; 2008; 5(2):358-63. PubMed ID: 18281942
[TBL] [Abstract][Full Text] [Related]
27. UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins.
Crupi V; Ficarra R; Guardo M; Majolino D; Stancanelli R; Venuti V
J Pharm Biomed Anal; 2007 May; 44(1):110-7. PubMed ID: 17379467
[TBL] [Abstract][Full Text] [Related]
28. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
[TBL] [Abstract][Full Text] [Related]
29. Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads.
Smith JS; Macrae RJ; Snowden MJ
Eur J Pharm Biopharm; 2005 May; 60(1):73-80. PubMed ID: 15848059
[TBL] [Abstract][Full Text] [Related]
30. Triamterene-beta-cyclodextrin systems: preparation, characterization and in vivo evaluation.
Mukne AP; Nagarsenker MS
AAPS PharmSciTech; 2004 Mar; 5(1):E19. PubMed ID: 15198540
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers.
Nie S; Zhang S; Pan W; Liu Y
Drug Dev Ind Pharm; 2011 May; 37(5):606-12. PubMed ID: 21469949
[TBL] [Abstract][Full Text] [Related]
32. Interactions of griseofulvin with cyclodextrins in solid binary systems.
Veiga MD; Díaz PJ; Ahsan F
J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360
[TBL] [Abstract][Full Text] [Related]
33. Complexation with beta-cyclodextrin confers oral activity on the flavonoid dioclein.
Rezende BA; Cortes SF; De Sousa FB; Lula IS; Schmitt M; Sinisterra RD; Lemos VS
Int J Pharm; 2009 Feb; 367(1-2):133-9. PubMed ID: 18955122
[TBL] [Abstract][Full Text] [Related]
34. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
35. Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers.
Li J; Xiao H; Li J; Zhong Y
Int J Pharm; 2004 Jul; 278(2):329-42. PubMed ID: 15196638
[TBL] [Abstract][Full Text] [Related]
36. The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats.
Dahan A; Hoffman A
Eur J Pharm Biopharm; 2007 Aug; 67(1):96-105. PubMed ID: 17329087
[TBL] [Abstract][Full Text] [Related]
37. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
[TBL] [Abstract][Full Text] [Related]
38. Loading antifungal drugs onto silica particles grafted with cyclodextrins by means of inclusion complex formation at the solid surface.
Hbaieb S; Kalfat R; Chevalier Y
Int J Pharm; 2012 Dec; 439(1-2):234-45. PubMed ID: 23018113
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and immobilization of micro-scale drug particles in presence of β-cyclodextrins.
Meng X; Yang D; Keyvan G; Michniak-Kohn B; Mitra S
Colloids Surf B Biointerfaces; 2012 Apr; 92():213-22. PubMed ID: 22186134
[TBL] [Abstract][Full Text] [Related]
40. Enhanced oral bioavailability of antiinflammatory drug flurbiprofen in rabbits by tri-O-methyl-beta-cyclodextrin complexation.
Otagiri M; Imai T; Uekama K
J Pharmacobiodyn; 1982 Dec; 5(12):1027-9. PubMed ID: 7169606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
